Ricerca avanzata

Home > Riviste > The Journal of Sports Medicine and Physical Fitness > Fascicoli precedenti > The Journal of Sports Medicine and Physical Fitness 2009 Dicembre;49(4) > The Journal of Sports Medicine and Physical Fitness 2009 Dicembre;49(4):448-52

FASCICOLI E ARTICOLI   I PIÙ LETTI   eTOC

ULTIMO FASCICOLOTHE JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS

Rivista di Medicina, Traumatologia e Psicologia dello Sport

Indexed/Abstracted in: Chemical Abstracts, CINAHL, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,111

Periodicità: Mensile

ISSN 0022-4707

Online ISSN 1827-1928

 

The Journal of Sports Medicine and Physical Fitness 2009 Dicembre;49(4):448-52

EPIDEMIOLOGY AND CLINICAL MEDICINE 

 Case reports

Aerobic exercise and non-alcoholic fatty liver disease: a case report

Di Mauro D. 1,2,3, Pagano F. 1,2,3, Magaudda L. 1,2,3, Speciale F. 1,2,3, Speranza G. 1,2, Bonaiuto M. 1,2, Mallamace A. 4, Trimarchi F. 1,2,3

1 Department of Biomorphology of Biotechnology, University of Messina, Messina, Italy;
2 School of Sports Medicine, University of Messina, Messina, Italy;
3 Interuniversitary Institute of Miology;
4 Clinical and Experimental Department of Medicine;
and Pharmacology, University of Messina, Messina, Italy

Non-alcoholic steatosis (non-alcoholic fatty liver disease [NAFLD]), now considered a metabolic pathway to advanced liver disease, cirrhosis and hepatocellular carcinoma, can also be explained by physical inactivity and increased dietary fat intake. No established treatment exists for this potentially serious disorder. The authors present the case of a 29-year-old man with NALFD who followed a restricted diet and practiced aerobic exercise for 16 weeks. Outcome after a combination therapy of aerobic exercise and diet was good, suggesting that treatment with a restricted diet and physical exercise can improve blood biochemical values in patients with NAFLD. Moderate-intensity aerobic exercise may help to normalize liver enzyme values and the quality of life of patients with fatty liver diseases.

lingua: Inglese


FULL TEXT  ESTRATTI

inizio pagina